Gp-2 Her2-derived Uses, Dosage, Side Effects and more
Gp-2 Her2-derived is under investigation in clinical trial NCT00524277 (Vaccine Therapy in Treating Patients With Breast Cancer).
| Trade Name | Gp-2 Her2-derived |
| Generic | GP2 peptide |
| GP2 peptide Other Names | Gp-2 her2-derived, hla-a2+ restricted peptide, GP2 peptide |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
